Risk of Hospitalized Infection With DMARD or TNF-I Therapy for Ankylosing Spondylitis

Article

Concerns have been raised in the past about the possibility of infection caused by immune suppression.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.